Back to Articles
45682026 Q3PrimeIFRS

DAIICHI SANKYO (4568) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥1.53T (+12.1% year on year) and operating income ¥233.8B (-5.9%). The segment drivers and cash flow follow.

Pharmaceutical


Quick View

MetricCurrentPriorYoY
Revenue¥15334.6B¥13675.7B+12.1%
Operating Income¥2337.8B¥2483.1B−5.9%
Profit Before Tax¥2699.5B¥2750.0B−1.8%
Net Income¥2174.5B¥2086.0B+4.2%
ROE12.7%12.8%-

Executive Summary

Performance Drivers

Segment Analysis

Key Metrics

Cash Flow Analysis

Earnings Quality

Guidance Update

Shareholder Returns

Catalysts

Industry Benchmark (Reference - Proprietary Data)

Risk Factors

Key Takeaways from Earnings


**